Eighty-six percent of people buying HealthCare.gov plans had at least three insurance companies to choose from this year.» Read More
On Oct. 1, all U.S. medical and billing codes will migrate to a new global standard, but is the health-care system ready for the change?
The uninsured rate among higher-income young adults was the first to drop, a new study found.
A new business plan has two Israeli doctors hoping for big changes when it comes to reducing joint pain.
Mark Cuban caused a Twitter storm recently, calling for everyone to get quarterly blood tests. He's half right, this doctor says.
The costs of false-positive mammograms and overdiagnosis of breast cancer top $4 billion annually, according to a new report.
NBC News reports on a study that finds some breast milk sold online actually contains cow's milk.
Today's vaccine debate will be outdated if Inovio succeeds in developing DNA vaccines. Imagine a single needle shot that can cure Ebola.
Federal law enforcement agencies recently contacted several Herbalife members for information about their own business practices, CNBC has learned.
An estimated 3 million Americans have autism. But what exactly what is it, and where are we on treatments?
Ventas said it would buy privately held hospital chain Ardent Medical Services for $1.75 billion in cash.
An intestinal illness called Shigellosis and carried by international travelers is spreading across the U.S., according to the Centers for Disease Control and Prevention.
The new Obamacare enrollment numbers show that you can't fix stupid, says Jake Novak. But wait—he's got an idea.
The government for the first time revealed how many people have signed up for HealthCare.gov plans during a special enrollment period.
A BMW ad featuring a "crazy" lady scaring a couple is drawing heat from a mental health advocacy group that wants the ad yanked.
E-cigarettes may have been marketed as a healthier option to cigarettes, yet, a new report shows that 1 in 5 U.K. teenagers have tried them.
As gene therapy emerges in the biotech industry, one analyst explains why it could be the next billion dollar industry.
A national pharmacists' group has adopted a policy discouraging its members from providing death-penalty drugs.
CNBC's Meg Tirrell reports on health care consolidation and PBM stocks to watch.
Teva said the deal would add a portfolio of drugs for the treatment of central nervous system disorders.
Officials have yet to keep their promise to disclose how many people are signing up during a special Obamacare enrollment season.
Get the best of CNBC in your inbox